Close

Analyst Ratings for Immunitybio Inc (IBRX)

IBRX Rating Summary

IBRX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on IBRX
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $4.50 (-4.5%) * Over Last 12-Mos
Rating Score: 5 / 10
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/12/2023 Piper Sandler Joseph Catanzaro Downgrade Neutral
(Overweight)
4.00
(10.00)
6.22
(4.71)
-24.28% Details
8/3/2022 Jefferies
» Updated 5/15/2023
Kelly Shi New Coverage Buy
(N/A)
5.00
(8.00)
3.65
(4.71)
29.04% Details
Like IBRX Ratings? Also take a look at AROW, GDS, STX, BTAI

IBRX Ratings News